Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
CLA3884 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A07330 | 32534588 | Cardiovasc Diabetol | Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study. | 2020 | Details |
| A07338 | 32531442 | Ann Diagn Pathol | Automated quantification and architectural pattern detection of hepatic fibrosis in NAFLD. | 2020 | Details |
| A07339 | 32531415 | J Hepatol | Non-alcoholic fatty liver disease in pregnancy is associated with adverse maternal and perinatal outcomes. | 2020 | Details |
| A07364 | 32525256 | IUBMB Life | APOC3rs2854116, PNPLA3rs738409, and TM6SF2rs58542926 polymorphisms might influence predisposition of NAFLD: A meta-analysis. | 2020 | Details |
| A07368 | 32524096 | Hawaii J Health Soc Welf | Nonalcoholic Fatty Liver Disease: An Important Consideration for Primary Care Providers in Hawai'i. | 2020 | Details |
| A07386 | 32518245 | Sci Rep | Self-reported snoring is associated with nonalcoholic fatty liver disease. | 2020 | Details |
| A07395 | 32515534 | Hepatol Res | Validation of albumin, bilirubin, and platelet criteria for avoiding screening endoscopy in patients with advanced fibrosis. | 2020 | Details |
| A07399 | 32514460 | JGH Open | Discordant pathological diagnosis of non-alcoholic fatty liver disease: A prospective multicenter study. | 2019 | Details |
| A07401 | 32514450 | JGH Open | Sodium-glucose cotransporter 2 inhibition does not reduce hepatic steatosis in overweight, insulin-resistant patients without type 2 diabetes. | 2019 | Details |
| A07432 | 32499918 | Gastroenterol Rep (Oxf) | Effect of Helicobacter pylori-eradication therapy on hepatic steatosis in patients with non-alcoholic fatty liver disease: a randomized-controlled pilot study. | 2019 | Details |
| A07458 | 32486399 | Int J Environ Res Public Health | Estimated Cardiorespiratory Fitness Attenuates the Impacts of Sarcopenia and Obesity on Non-Alcoholic Fatty Liver in Korean Adults. | 2020 | Details |
| A07463 | 32485811 | Int J Mol Sci | Relevance of SIRT1-NF-κB Axis as Therapeutic Target to Ameliorate Inflammation in Liver Disease. | 2020 | Details |
| A07490 | 32475980 | Med Sci Monit | Analysis of Risk Factors for Adverse Cardiovascular Events in Elderly Patients with Acute Myocardial Infarction and Non-Alcoholic Fatty Liver Disease (NAFLD). | 2020 | Details |
| A07509 | 32463622 | Clin Transl Gastroenterol | Reduced Lysosomal Acid Lipase Activity in Blood and Platelets Is Associated With Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A07524 | 32455496 | Hepatol Res | Metabolomic/lipidomic-based analysis of plasma to diagnose hepatocellular ballooning in patients with non-alcoholic fatty liver disease: A multicenter study. | 2020 | Details |
| A07546 | 32447913 | Zhonghua Liu Xing Bing Xue Za Zhi | [Association between tooth missing and non-alcoholic fatty liver disease]. | 2020 | Details |
| A07584 | 32435522 | World J Gastrointest Pathophysiol | Non-alcoholic fatty liver disease and Atherosclerosis at a crossroad: The overlap of a theory of change and bioinformatics. | 2020 | Details |
| A07593 | 32431528 | Diabetes Metab Syndr Obes | Association Between Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome with Gallstone Disease, South Iran: A Population-Based Study. | 2020 | Details |
| A07599 | 32429590 | Nutrients | Changed Amino Acids in NAFLD and Liver Fibrosis: A Large Cross-Sectional Study without Influence of Insulin Resistance. | 2020 | Details |
| A07610 | 32423665 | Nutr Metab Cardiovasc Dis | Healthcare resource utilization and costs of nonalcoholic steatohepatitis patients with advanced liver disease in Italy. | 2020 | Details |
| A07632 | 32414383 | Ann Clin Microbiol Antimicrob | Plasma CRP level is positively associated with the severity of COVID-19. | 2020 | Details |
| A07636 | 32413340 | Lancet Gastroenterol Hepatol | Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. | 2020 | Details |
| A07639 | 32411211 | Gastroenterol Res Pract | Nonalcoholic Fatty Liver Disease Is Associated with Helicobacter pylori Infection in North Urban Chinese: A Retrospective Study. | 2020 | Details |
| A07653 | 32407969 | Clin Gastroenterol Hepatol | Associations Between Nonalcoholic Fatty Liver Disease and Cancers in a Large Cohort in China. | 2020 | Details |
| A07662 | 32405180 | J Clin Exp Hepatol | Effect of Donor Hepatic Steatosis on Ischemia Reperfusion Injury in Liver Transplant Recipient. | 2019 | Details |
| A07678 | 32396388 | Am J Physiol Endocrinol Metab | β-Hydroxybutyrate is reduced in humans with obesity-related NAFLD and displays a dose-dependent effect on skeletal muscle mitochondrial respiration in vitro. | 2020 | Details |
| A07680 | 32392802 | Int J Mol Sci | Short-Term Western Diet Aggravates Non-Alcoholic Fatty Liver Disease (NAFLD) With Portal Hypertension in TGR(mREN2)27 Rats. | 2020 | Details |
| A07689 | 32390455 | Antioxid Redox Signal | Intestinal Dysbiosis and Development of Cardiometabolic Disorders in Childhood Cancer Survivors: A Critical Review. | 2020 | Details |
| A07705 | 32384501 | Medicine (Baltimore) | Vitamin D supplementation for nonalcoholic fatty liver disease in type 2 diabetes mellitus: A protocol for a systematic review and meta-analysis. | 2020 | Details |
| A07717 | 32377814 | Eur Radiol | Liver extracellular volume fraction values obtained with magnetic resonance imaging can quantitatively stage liver fibrosis: a validation study in monkeys with nonalcoholic steatohepatitis. | 2020 | Details |
| A07718 | 32377366 | BMJ Open Gastroenterol | Antitumour necrosis factor-α agents and development of new-onset cirrhosis or non-alcoholic fatty liver disease: a retrospective cohort. | 2020 | Details |
| A07722 | 32376267 | Life Sci | Heme oxygenase-1 alleviated non-alcoholic fatty liver disease via suppressing ROS-dependent endoplasmic reticulum stress. | 2020 | Details |
| A07724 | 32375660 | BMC Gastroenterol | Association between NAFLD and risk of prevalent chronic kidney disease: why there is a difference between east and west? | 2020 | Details |
| A07731 | 32373213 | Theranostics | PTPROt aggravates inflammation by enhancing NF-κB activation in liver macrophages during nonalcoholic steatohepatitis. | 2020 | Details |
| A07732 | 32372515 | Aliment Pharmacol Ther | Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare data. | 2020 | Details |
| A07776 | 32357561 | Int J Mol Sci | The Molecular and Mechanistic Insights Based on Gut-Liver Axis: Nutritional Target for Non-Alcoholic Fatty Liver Disease (NAFLD) Improvement. | 2020 | Details |
| A07779 | 32356922 | Diabetes Metab Res Rev | Non-alcoholic fatty liver disease is associated with cardiovascular disease in subjects with different glucose tolerance. | 2020 | Details |
| A07792 | 32353483 | J Hepatol | Standardisation of diet and exercise in clinical trials of NAFLD-NASH: Recommendations from the Liver Forum. | 2020 | Details |
| A07793 | 32353385 | Toxicol Appl Pharmacol | Metabolomic-based assessment reveals dysregulation of lipid profiles in human liver cells exposed to environmental obesogens. | 2020 | Details |
| A07820 | 32345506 | Rev Gastroenterol Mex (Engl Ed) | Hepatocellular carcinoma in the noncirrhotic liver: Clinical features and outcomes in Veracruz, Mexico. | 2020 | Details |
| A07867 | 32329657 | Gut Microbes | Microbial and metabolic impacts of trehalose and trehalose analogues. | 2020 | Details |
| A07879 | 32325349 | Biomed Pharmacother | Gan-Jiang-Ling-Zhu decoction alleviates hepatic steatosis in rats by the miR-138-5p/CPT1B axis. | 2020 | Details |
| A07894 | 32318847 | Eur Radiol | Prospective comparison of longitudinal change in hepatic proton density fat fraction (PDFF) estimated by magnitude-based MRI (MRI-M) and complex-based MRI (MRI-C). | 2020 | Details |
| A07910 | 32314167 | Indian J Gastroenterol | Metabolic syndrome is not uncommon among lean non-alcoholic fatty liver disease patients as compared with those with obesity. | 2020 | Details |
| A07914 | 32312689 | Best Pract Res Clin Obstet Gynaecol | Implications of abnormal liver function in pregnancy and non-alcoholic fatty liver disease. | 2020 | Details |
| A07938 | 32304952 | Environ Pollut | Exposure to 2,3,3',4,4',5-hexachlorobiphenyl promotes nonalcoholic fatty liver disease development in C57BL/6 mice. | 2020 | Details |
| A07945 | 32303004 | Aging (Albany NY) | Ultraconserved element uc.333 increases insulin sensitivity by binding to miR-223. | 2020 | Details |
| A07951 | 32301554 | Liver Int | What's in a name? Renaming 'NAFLD' to 'MAFLD'. | 2020 | Details |
| A07988 | 32289180 | Eur J Clin Invest | Prevalence and risk factors of fatty liver in Portuguese adults. | 2020 | Details |
| A08025 | 32278004 | J Hepatol | A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. | 2020 | Details |
| A08046 | 32270583 | J Diabetes Investig | Increased risks of different grades of non-alcoholic fatty liver disease in prediabetic subjects with impaired fasting glucose and glucose tolerance, including the isolated glycosylated hemoglobin levels of 5.7-6.4% in a Chinese population. | 2020 | Details |
| A08056 | 32267017 | J Clin Lab Anal | Revision of serum ALT upper limits of normal facilitates assessment of mild liver injury in obese children with non-alcoholic fatty liver disease. | 2020 | Details |
| A08063 | 32259482 | Cell Metab | Cholesterol Stabilizes TAZ in Hepatocytes to Promote Experimental Non-alcoholic Steatohepatitis. | 2020 | Details |
| A08083 | 32253813 | J Cell Mol Med | Enhanced liver but not muscle OXPHOS in diabetes and reduced glucose output by complex I inhibition. | 2020 | Details |
| A08111 | 32243703 | Liver Int | Bile acids associate with specific gut microbiota, low-level alcohol consumption and liver fibrosis in patients with non-alcoholic fatty liver disease. | 2020 | Details |
| A08115 | 32241197 | Expert Rev Gastroenterol Hepatol | Obeticholic acid for the treatment of nonalcoholic steatohepatitis. | 2020 | Details |
| A08124 | 32239220 | JAMA Netw Open | Trends in the Burden of Chronic Liver Disease Among Hospitalized US Adults. | 2020 | Details |
| A08150 | 32228300 | Gut Microbes | Maternal sucralose intake alters gut microbiota of offspring and exacerbates hepatic steatosis in adulthood. | 2020 | Details |
| A08187 | 32213734 | Endocr J | The risk factors for hepatic steatosis in patients with primary aldosteronism. | 2020 | Details |
| A08209 | 32204538 | Nutrients | Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study in Taiwan. | 2020 | Details |
| A08210 | 32203743 | Atherosclerosis | Advanced fibrosis of non-alcoholic steatohepatitis affects the significance of lipoprotein(a) as a cardiovascular risk factor. | 2020 | Details |
| A08221 | 32195455 | JHEP Rep | Higher phenolic acid intake independently associates with lower prevalence of insulin resistance and non-alcoholic fatty liver disease. | 2020 | Details |
| A08233 | 32191646 | J Clin Invest | Influence of adiposity, insulin resistance, and intrahepatic triglyceride content on insulin kinetics. | 2020 | Details |
| A08239 | 32190810 | Curr Dev Nutr | Diet Quality Association with Nonalcoholic Fatty Liver Disease by Cirrhosis Status: The Multiethnic Cohort. | 2020 | Details |
| A08273 | 32175323 | Front Med (Lausanne) | Hepatic Autonomic Nervous System and Neurotrophic Factors Regulate the Pathogenesis and Progression of Non-alcoholic Fatty Liver Disease. | 2020 | Details |
| A08283 | 32169759 | Biomed Pharmacother | Gegen Qinlian Decoction abates nonalcoholic steatohepatitis associated liver injuries via anti-oxidative stress and anti-inflammatory response involved inhibition of toll-like receptor 4 signaling pathways. | 2020 | Details |
| A08286 | 32169417 | Biochem Pharmacol | Modulation of aryl hydrocarbon receptor (AHR) and the NAD+-consuming enzyme CD38: Searches of therapeutic options for nonalcoholic fatty liver disease (NAFLD). | 2020 | Details |
| A08291 | 32168133 | J Clin Gastroenterol | Accuracy of Noninvasive Fibrosis Scores to Detect Advanced Fibrosis in Patients With Type-2 Diabetes With Biopsy-proven Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A08298 | 32163832 | J Nutr Biochem | Housing condition-associated changes in gut microbiota further affect the host response to diet-induced nonalcoholic fatty liver. | 2020 | Details |
| A08301 | 32161197 | JCI Insight | Hydroxysteroid 17-β dehydrogenase 13 variant increases phospholipids and protects against fibrosis in nonalcoholic fatty liver disease. | 2020 | Details |
| A08323 | 32152677 | Surg Endosc | Impact of laparoscopic sleeve gastrectomy on fibrosis stage in patients with child-A NASH-related cirrhosis. | 2020 | Details |
| A08324 | 32152511 | Eur J Clin Nutr | Association of grip strength with non-alcoholic fatty liver disease: investigation of the roles of insulin resistance and inflammation as mediators. | 2020 | Details |
| A08336 | 32149275 | JHEP Rep | Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism. | 2019 | Details |
| A08340 | 32147742 | Acta Derm Venereol | Molecular Genetics of Keratinization Disorders - What's New About Ichthyosis. | 2020 | Details |
| A08357 | 32145139 | BJOG | Overweight and obesity status from the prenatal period to adolescence and its association with non-alcoholic fatty liver disease in young adults: cohort study. | 2020 | Details |
| A08371 | 32139740 | Sci Rep | Odontogenic infection by Porphyromonas gingivalis exacerbates fibrosis in NASH via hepatic stellate cell activation. | 2020 | Details |
| A08378 | 32135539 | Dig Dis | Sarcopenia Is a New Risk Factor of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Disease. | 2020 | Details |
| A08404 | 32124221 | Obes Surg | Are Noninvasive Methods Comparable to Liver Biopsy in Postoperative Patients After Roux-en-Y Gastric Bypass? | 2020 | Details |
| A08441 | 32110174 | Food Nutr Res | Purple sweet potato color protects against hepatocyte apoptosis through Sirt1 activation in high-fat-diet-treated mice. | 2020 | Details |
| A08443 | 32109637 | Clin Gastroenterol Hepatol | Longitudinal Change in Thyroid-Stimulating Hormone and Risk of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A08457 | 32104030 | Diabetes Metab Syndr Obes | A Pilot Study Assessing the Possible Combined Effect of Physical Activity and PNPLA3 rs738409 Polymorphism on the Risk for Non-Alcoholic Fatty Liver Disease in the Japanese Elderly General Population. | 2020 | Details |
| A08458 | 32104026 | Diabetes Metab Syndr Obes | Novel Application of the Traditional Lipid Ratios as Strong Risk Predictors of NASH. | 2020 | Details |
| A08473 | 32096706 | Radiology | Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat with Radiofrequency Ultrasound Data Using One-dimensional Convolutional Neural Networks. | 2020 | Details |
| A08528 | 32073443 | Eur J Gastroenterol Hepatol | The association of nonalcoholic steatohepatitis and hepatocellular carcinoma. | 2020 | Details |
| A08541 | 32067588 | J Am Heart Assoc | Longitudinal Association of Non-Alcoholic Fatty Liver Disease With Changes in Myocardial Structure and Function: The CARDIA Study. | 2020 | Details |
| A08544 | 32066758 | Sci Rep | A Microbial Signature Identifies Advanced Fibrosis in Patients with Chronic Liver Disease Mainly Due to NAFLD. | 2020 | Details |
| A08551 | 32064187 | Cureus | Ketogenic Diet-induced Elevated Cholesterol, Elevated Liver Enzymes and Potential Non-alcoholic Fatty Liver Disease. | 2020 | Details |
| A08582 | 32051820 | Can J Gastroenterol Hepatol | Natural History of Nonalcoholic Fatty Liver Disease: Implications for Clinical Practice and an Individualized Approach. | 2020 | Details |
| A08603 | 32044314 | Gastroenterology | MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease. | 2020 | Details |
| A08616 | 32040895 | Klin Lab Diagn | [The Diagnostic Importance of Circulating MicroRNA for Non-Alcoholic Fatty Liver Disease (review of literature).] | 2019 | Details |
| A08641 | 32033865 | Trends Endocrinol Metab | Chronic Diabetes Complications: The Need to Move beyond Classical Concepts. | 2020 | Details |
| A08653 | 32033757 | Gastroenterol Clin North Am | Burden of Disease due to Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A08654 | 32033223 | Nutrients | Beneficial Effects of a Low-dose of Conjugated Linoleic Acid on Body Weight Gain and other Cardiometabolic Risk Factors in Cafeteria Diet-fed Rats. | 2020 | Details |
| A08669 | 32027858 | Lancet Gastroenterol Hepatol | FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study. | 2020 | Details |
| A08686 | 32022277 | Hepatology | Risk of Cirrhosis and Hepatocellular Cancer in Patients With NAFLD and Normal Liver Enzymes. | 2020 | Details |
| A08702 | 32017849 | J Med Chem | [1,2,5]Oxadiazolo[3,4-b]pyrazine-5,6-diamine Derivatives as Mitochondrial Uncouplers for the Potential Treatment of Nonalcoholic Steatohepatitis. | 2020 | Details |
| A08713 | 32014594 | Int J Surg | Impact of sleeve gastrectomy and dietary change on metabolic and hepatic function in an obesity rat model - Experimental research. | 2020 | Details |
| A08714 | 32013841 | Curr Pharm Des | Lifestyle Changes for the Treatment of Nonalcoholic Fatty Liver Disease - A 2015-19 Update. | 2020 | Details |
| A08715 | 32013792 | Radiology | Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease by Using Quantitative US. | 2020 | Details |
| A08717 | 32012320 | Hepatology | Epidemiological Features of NAFLD From 1999 to 2018 in China. | 2020 | Details |